Geoffrey Burnstock

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Jump to: navigation, search

Geoffrey Burnstock, PhD, (b. 1929) is best known for his discovery that ATP (adenosine triphosphate) is a transmitter in NANC (non-adrenergic, non-cholinergic) nerves and also for the discovery and definition of P2 purinergic receptors, their receptors, their signaling pathways and their functional relevance. He has applied his research to the understanding of pain mechanisms, as well as many other areas not related to ME/CFS.[1]

Talks and interviews[edit | edit source]

Awards[edit | edit source]

  • Australian Academy of Science
  • Royal Academy of Medical Sciences
  • Royal Society Gold medal in 2000
  • President of the International Society for Autonomic Neuroscience (ISAN)

References[edit | edit source]

cholinergic Involving the neurotransmitter acetylcholine. Cholinergic side effects include diarrhea, blurred vision, decreased intraocular pressure, contricted pupil in the eyes, sweating, increased saliva and mucus on the lungs, bronchial constriction, increased gastrointestinal tone, decreased blood pressure, slow heart rate, and contraction of bladder detrusor muscle. muscle spasms/cramps, low blood pressure, slowed heart rate, nausea and vomiting, increased saliva and sweating, shortness of breath, and urinating more often.

The information provided at this site is not intended to diagnose or treat any illness.
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history.